Market Cap ₹5321 Cr.
Stock P/E 67.6
P/B 7.2
Current Price ₹445.6
Book Value ₹ 61.5
Face Value 1
52W High ₹459
Dividend Yield 0%
52W Low ₹ 284.1
Borosil Ltd operates as glassware agency in India. It operates through Scientific ware, Consumer ware, and Investments segments. The enterprise offers science and industrial products, together with laboratory glassware, units, disposable plastics, liquid managing structures, explosion proof lighting fixtures glassware, glass ampoules, and tabular glass vials underneath the LabQuest brand name which can be utilized in pharmaceutical, studies and development, education, and healthcare sectors. It also offers primary glass packaging below the Klasspack name for pharma enterprise. In addition, the business enterprise offers customer glassware products, along with microwaveable kitchenware, opal dining ware, kitchen appliances, storage merchandise, lunch containers, and stainless-steel flasks underneath the Borosil logo name. Further, it engages within the investment activities. The organisation sells its products through distributors and retail outlets, as well as thru online platform. It also exports its merchandise to the Middle East, South East Asia, Africa, and U.S. The employer become previously known as Hopewell Tableware Ltd. Borosil Ltd was founded in 1962 and is based totally in Mumbai, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 345 | 591 | 527 | 750 | 742 | 942 | |
| Other Income | 16 | 13 | 17 | 24 | 20 | 21 | |
| Total Income | 361 | 603 | 544 | 774 | 762 | 963 | |
| Total Expenditure | 296 | 516 | 452 | 623 | 675 | 812 | |
| Operating Profit | 65 | 88 | 92 | 151 | 87 | 151 | |
| Interest | 9 | 5 | 2 | 1 | 3 | 9 | |
| Depreciation | 24 | 33 | 30 | 27 | 28 | 54 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | -11 | 9 | 0 | |
| Profit Before Tax | 32 | 50 | 60 | 112 | 66 | 88 | |
| Provision for Tax | 8 | 9 | 20 | 34 | 14 | 22 | |
| Profit After Tax | 24 | 41 | 41 | 77 | 52 | 66 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 24 | 41 | 41 | 77 | 52 | 66 | |
| Adjusted Earnings Per Share | 0 | 3.6 | 3.6 | 6.8 | 4.5 | 5.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 27% | 21% | 22% | 0% |
| Operating Profit CAGR | 74% | 18% | 18% | 0% |
| PAT CAGR | 27% | 17% | 22% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 11% | 14% | NA% | NA% |
| ROE Average | 12% | 10% | 9% | 8% |
| ROCE Average | 15% | 13% | 11% | 10% |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 614 | 654 | 700 | 768 | 510 | 580 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 0 | 0 | 0 | 53 | 93 |
| Other Non-Current Liabilities | 12 | 8 | 18 | 22 | 14 | 22 |
| Total Current Liabilities | 157 | 149 | 107 | 132 | 273 | 385 |
| Total Liabilities | 783 | 811 | 825 | 922 | 850 | 1080 |
| Fixed Assets | 288 | 265 | 281 | 208 | 352 | 547 |
| Other Non-Current Assets | 161 | 195 | 143 | 206 | 117 | 78 |
| Total Current Assets | 334 | 349 | 401 | 447 | 344 | 455 |
| Total Assets | 783 | 811 | 825 | 922 | 850 | 1080 |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 7 | 2 | 6 | 22 | 8 |
| Cash Flow from Operating Activities | 44 | 50 | 180 | 68 | 121 | 48 |
| Cash Flow from Investing Activities | -25 | -32 | -133 | -36 | -228 | -106 |
| Cash Flow from Financing Activities | -17 | -22 | -44 | -16 | 93 | 55 |
| Net Cash Inflow / Outflow | 2 | -5 | 3 | 17 | -14 | -3 |
| Closing Cash & Cash Equivalent | 7 | 2 | 6 | 22 | 8 | 5 |
| # | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 3.61 | 3.57 | 6.79 | 4.53 | 5.75 |
| CEPS(Rs) | 0 | 6.46 | 6.17 | 9.16 | 6.94 | 10.45 |
| DPS(Rs) | 0 | 0 | 1 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0 | 57.36 | 61.03 | 66.86 | 44.15 | 50.19 |
| Core EBITDA Margin(%) | 14.23 | 12.71 | 14.18 | 16.91 | 9 | 13.78 |
| EBIT Margin(%) | 11.92 | 9.33 | 11.78 | 14.99 | 9.24 | 10.25 |
| Pre Tax Margin(%) | 9.2 | 8.54 | 11.45 | 14.88 | 8.9 | 9.32 |
| PAT Margin (%) | 6.85 | 6.96 | 7.73 | 10.32 | 7 | 6.99 |
| Cash Profit Margin (%) | 13.68 | 12.48 | 13.35 | 13.94 | 10.71 | 12.71 |
| ROA(%) | 3.02 | 5.16 | 4.98 | 8.87 | 5.86 | 6.83 |
| ROE(%) | 3.93 | 6.55 | 6.04 | 10.61 | 8.18 | 12.2 |
| ROCE(%) | 6.1 | 8.03 | 8.89 | 15.33 | 10.03 | 14.5 |
| Receivable days | 85.03 | 48.73 | 45.41 | 27.77 | 27.48 | 27.65 |
| Inventory Days | 173.62 | 103.43 | 103.96 | 73.42 | 77.89 | 76.93 |
| Payable days | 144.14 | 62.25 | 58.89 | 56.16 | 47.77 | 62.16 |
| PER(x) | 0 | 0 | 47.28 | 48.83 | 72.21 | 62.12 |
| Price/Book(x) | 0 | 0 | 2.77 | 4.96 | 7.42 | 7.11 |
| Dividend Yield(%) | 0 | 0 | 0.59 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0 | 0.09 | 3.64 | 5 | 5.16 | 4.5 |
| EV/Core EBITDA(x) | 0 | 0.6 | 20.95 | 24.9 | 44.09 | 28.16 |
| Net Sales Growth(%) | 0 | 71.1 | -10.76 | 42.33 | -1.18 | 27.06 |
| EBIT Growth(%) | 0 | 33.87 | 12.69 | 81.11 | -39.07 | 40.98 |
| PAT Growth(%) | 0 | 73.94 | -0.91 | 90.02 | -33.04 | 26.97 |
| EPS Growth(%) | 0 | 0 | -0.96 | 89.95 | -33.19 | 26.79 |
| Debt/Equity(x) | 0.1 | 0.07 | 0 | 0 | 0.17 | 0.27 |
| Current Ratio(x) | 2.13 | 2.34 | 3.75 | 3.38 | 1.26 | 1.18 |
| Quick Ratio(x) | 1.08 | 1.2 | 2.54 | 2.08 | 0.73 | 0.53 |
| Interest Cover(x) | 4.38 | 11.79 | 35.25 | 139.68 | 27.26 | 11.02 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.02 | 0.04 |
| # | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.44 | 70.4 | 70.33 | 70.3 | 70.28 | 70.28 | 70.21 | 70.18 | 70.18 | 67.41 |
| FII | 2.71 | 2.12 | 1.78 | 2.07 | 2.13 | 2.14 | 0.71 | 0.78 | 0.85 | 1.87 |
| DII | 0.06 | 0.14 | 0.17 | 0.19 | 0.19 | 0.2 | 1.32 | 1.39 | 1.46 | 3.81 |
| Public | 26.8 | 27.35 | 27.72 | 27.44 | 27.39 | 27.39 | 27.76 | 27.64 | 27.51 | 26.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 8.04 | 8.04 | 8.04 | 8.04 | 8.04 | 8.04 | 8.04 | 8.04 | 8.04 | 8.04 |
| FII | 0.31 | 0.24 | 0.2 | 0.24 | 0.24 | 0.25 | 0.08 | 0.09 | 0.1 | 0.22 |
| DII | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.15 | 0.16 | 0.17 | 0.45 |
| Public | 3.06 | 3.12 | 3.17 | 3.14 | 3.13 | 3.13 | 3.18 | 3.17 | 3.15 | 3.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11.42 | 11.42 | 11.43 | 11.44 | 11.44 | 11.44 | 11.45 | 11.46 | 11.46 | 11.93 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
